S&P 500 Futures
(0.01%) 5 479.25 points
Dow Jones Futures
(-0.01%) 38 815 points
Nasdaq Futures
(0.05%) 19 931 points
Oil
(0.30%) $80.57
Gas
(0.54%) $2.80
Gold
(0.15%) $2 332.60
Silver
(-0.24%) $29.32
Platinum
(-0.04%) $970.50
USD/EUR
(0.00%) $0.932
USD/NOK
(-0.14%) $10.64
USD/GBP
(0.07%) $0.788
USD/RUB
(-1.87%) $86.80

Realaus laiko atnaujinimai Metacrine, Inc. [MTCR]

Birža: NASDAQ Sektorius: Healthcare Pramonė: Biotechnology
Atnaujinta20 birž. 2023 @ 22:11

-1.29% $ 0.581

Live Chart Being Loaded With Signals

Commentary (20 birž. 2023 @ 22:11):

Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases...

Stats
Šios dienos apimtis 83 889
Vidutinė apimtis 52 473
Rinkos kapitalizacija 25.48M
EPS $-0.130 ( Q3 | 2022-11-14 )
Last Dividend $0.580 ( 2023-06-21 )
Next Dividend $0 ( N/A )
P/E -0.564
(Sector) 42.63
(Industry) 24.32
ATR14 $0.0160 (2.75%)
AADI 0.00%
ABCL 0.65%
ABCM 0.04%
ABEO -0.44%
ABIO 2.17%
ABOS -0.40%
ABSI 0.55%
ABUS 0.33%
ABVX -0.22%
ACAD 0.54%
ACER -17.95%
ACET 0.00%
ACGN 1.29%
ACHL -2.44%
ACHV 1.63%
ACIU 0.00%
ACLX 0.28%
ACRV 0.73%
ACST 0.62%
ACXP 1.68%
ADAG -5.64%
ADAP 0.33%
ADGI 0.87%
ADIL 1.57%
ADMA 0.19%
ADPT -0.96%
ADTX -1.27%
ADVM -0.55%
ADXN -6.11%
AEON 11.51%
AEZS -5.44%
AFMD -0.59%
AGEN -1.89%
AGIO 0.56%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW 53.45%
AKBA -0.95%
AKRO 0.26%
AKTX -2.70%
AKUS 0.00%
ALBO 0.00%
ALDX 0.96%
ALEC 0.44%
ALGS -0.25%
ALKS 0.34%
ALLK -0.85%
ALLO -0.43%
ALLR -2.32%
ALNA 3.16%
ALNY -0.01%
ALPN 0.00%
ALPX 0.00%
ALRN -0.31%
ALT -0.76%
ALVR 0.60%
ALXN 0.00%
ALXO -1.49%
ALZN 0.00%
AMRN -0.52%
AMTI -3.13%
ANAB -0.94%
ANEB -5.58%
ANGN 0.00%
ANIX -1.14%
ANL 0.61%
ANNX -0.93%
ANPC -3.15%
APGE 0.36%
APGN 8.48%
APGNW 30.65%
APLM 10.18%
APLS 0.15%
APLT 0.21%
APM 1.33%
APOP 0.38%
APRE 2.44%
APTO 0.68%
APTX 3.17%
APVO -0.02%
ARAV -13.39%
ARCT -0.44%
ARDS 20.48%
ARDX 0.32%
ARGX 0.19%
ARNA 0.00%
ARPO -0.90%
ARQT -1.38%
ARTL -4.55%
ARTLW 9.80%
ARVN -0.60%
ARWR 0.00%
ASLN 2.75%
ASMB -0.86%
ASND 0.41%
ATAI 0.75%
ATHA -0.38%
ATHE -1.61%
ATHX -33.50%
ATNF -4.37%
ATOS 2.16%
ATRA -2.26%
ATXI -1.66%
ATXS 0.45%
AUPH -0.36%
AURA 0.68%
AUTL -0.23%
AVBP -0.27%
AVEO 0.00%
AVIR -0.28%
AVRO -2.05%
AVTE -4.85%
AVTX 4.15%
AVXL -0.13%
AXLA 0.00%
AXSM 0.07%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 1.40%
BCAB 1.92%
BCDA -0.30%
BCDAW -33.33%
BCEL -1.32%
BCLI -0.05%
BCRX -0.24%
BCTX -0.68%
BCTXW 0.00%
BCYC 0.00%
BDRX 1.05%
BDTX -0.55%
BEAM -0.12%
BFRA -2.91%
BGNE -1.47%
BIOR 0.03%
BIVI 1.73%
BLCM -6.68%
BLI -5.88%
BLPH -0.79%
BLRX 2.36%
BLTE -0.72%
BLU 0.03%
BLUE -0.61%
BMEA -0.57%
BMRN 0.19%
BNOX 10.76%
BNTC 2.46%
BNTX 0.19%
BOLD 0.49%
BOLT -0.50%
BPMC 0.35%
BPTH 1.26%
BPTS -13.47%
BRNS 2.96%
BRTX -9.90%
BTAI 0.75%
BTTX -7.50%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 0.00%
CABA -2.22%
CADL -0.83%
CALA 60.00%
CALC -1.62%
CALT -0.64%
CAPR -0.60%
CARA 2.71%
CARM 0.97%
CASI -2.41%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS 2.61%
CCCC -1.09%
CCXI 0.00%
CDAK 0.00%
CDIO -3.01%
CDIOW 0.00%
CDMO -0.40%
CDMOP 0.04%
CDT -6.11%
CDTTW 294.32%
CDTX -0.08%
CDXC -1.19%
CDXS -1.49%
CELC 1.03%
CELU 7.05%
CELUW -9.52%
CERC -1.68%
CERE 0.41%
CERO -4.29%
CEROW -44.78%
CFRX -27.95%
CGEM -1.95%
CGEN -1.02%
CGON 0.00%
CGTX 1.39%
CHMA -6.00%
CHRS -0.01%
CINC 0.00%
CING 4.48%
CINGW -48.24%
CKPT -0.49%
CLBS -16.75%
CLDX 2.89%
CLGN 0.30%
CLLS -6.54%
CLNN 6.88%
CLNNW -41.25%
CLRB 0.64%
CLSD 0.86%
CLSN -0.68%
CLVS 0.00%
CMMB 10.18%
CMND 1.82%
CMPI 0.00%
CMPX 0.00%
CMRA 0.40%
CMRAW 33.33%
CMRX 1.11%
CNCE 0.00%
CNSP -1.73%
CNST 0.00%
CNTA 0.31%
CNTB 3.13%
CNTX -1.03%
COCP 0.42%
COEPW -0.66%
COGT -0.11%
CORT 0.10%
COYA 2.22%
CPRX 0.00%
CRBP -2.67%
CRBU 0.00%
CRDF -0.75%
CRGX 0.00%
CRIS 0.73%
CRNX -0.16%
CRSP 0.51%
CRTX 2.63%
CRVO -1.89%
CRVS 0.00%
CSBR 1.19%
CTCX -8.04%
CTIC 0.06%
CTMX 3.65%
CTNM -2.94%
CTXR -1.01%
CUE -0.75%
CVAC 0.86%
CVKD 1.37%
CWBR -2.55%
CYAD -12.96%
CYCC -2.45%
CYCCP -1.79%
CYCN 6.00%
CYT -2.27%
CYTK -0.13%
CYTO -3.23%
DARE 1.19%
DAWN 0.42%
DBTX -0.81%
DBVT 1.01%
DFFN 10.28%
DICE 0.06%
DMAC -0.42%
DNLI 1.12%
DNTH 0.04%
DOMH 1.99%
DRMA 0.00%
DRMAW 0.00%
DRNA 0.00%
DRTS -1.32%
DRTSW 1.01%
DRUG 0.00%
DSGN 0.00%
DTIL -1.19%
DYAI -5.29%
EARS -1.77%
EDIT 4.31%
EDSA 1.04%
EFTR -3.13%
EFTRW -0.26%
EIGR 0.00%
ELAB -2.87%
ELDN 0.71%
ELEV -0.84%
ELOX -12.50%
ELTX -2.33%
ELVN -0.65%
ELYM 0.52%
ENGN -3.89%
ENGNW -5.29%
ENLV 0.73%
ENOB 1.79%
ENSC 0.88%
ENTA -0.75%
ENTO 0.48%
ENTX 1.45%
ENVB 0.94%
EPIX 0.00%
EPRX -0.19%
EPZM 0.00%
EQ 1.40%
EQRX -2.09%
EQRXW 0.00%
ERAS -0.50%
ERNA 4.79%
ERYP 1.30%
ESLA 1.14%
ESLAW -9.25%
ETNB -0.23%
ETON 1.19%
ETTX 0.00%
EVAX 4.45%
EVGN -2.55%
EVLO 50.00%
EWTX -0.58%
EXAI -0.20%
EXEL -0.30%
EYEG -0.43%
EYEN -0.33%
EYPT 0.00%
FATE 0.42%
FBIO 0.53%
FBIOP 1.09%
FBLG -1.17%
FBRX -7.46%
FDMT -0.67%
FENC 0.74%
FGEN 0.47%
FHTX 9.52%
FIXX 0.77%
FMTX 0.00%
FNCH -6.25%
FOLD 0.30%
FREQ 4.76%
FRLN 0.15%
FRTX -0.54%
FSTX 0.00%
FTRE 0.58%
FULC 0.00%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT 3.20%
GANX -0.76%
GBIO 1.37%
GBT 0.01%
GDTC -7.21%
GERN -0.96%
GHRS 3.42%
GLMD -3.30%
GLPG 0.93%
GLSI -1.83%
GLTO 0.00%
GLUE 0.00%
GLYC 2.57%
GMAB 0.95%
GMDA 0.00%
GMTX 0.00%
GNCA -85.71%
GNFT 0.97%
GNLX 0.00%
GNPX 1.84%
GNTA 0.00%
GOSS 11.54%
GOVX 19.82%
GOVXW -24.72%
GPCR 0.94%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -1.42%
GRTX -4.26%
GTHX 0.75%
GUTS 0.28%
GXGXW 41.67%
GYRE 0.17%
HALO 0.48%
HARP 0.09%
HCWB -9.73%
HEPA -6.36%
HGEN -84.62%
HILS 5.66%
HLVX 0.00%
HOOK 0.56%
HOTH -3.73%
HOWL -1.27%
HRMY 0.00%
HRTX 1.40%
HSTO 62.16%
HUMA -0.32%
HUMAW -5.97%
IBRX -0.34%
ICCC 2.84%
ICPT 0.21%
ICU -0.26%
ICUCW -10.39%
ICVX -0.91%
IDRA -23.04%
IDYA -0.13%
IFRX -3.21%
IGMS 0.14%
IKNA 1.15%
IKT 8.90%
IMAB -1.10%
IMCR -0.81%
IMGN 0.02%
IMGO 0.00%
IMMP -1.47%
IMMX -0.49%
IMNM 0.00%
IMNN -0.90%
IMPL -27.27%
IMRA 15.96%
IMRN -2.78%
IMRX 0.32%
IMTX -0.85%
IMTXW -2.70%
IMUX 1.75%
IMV 0.00%
IMVT -1.34%
INAB -0.02%
INBX -0.35%
INCY 0.01%
INDP -3.03%
INFI -52.38%
INKT -0.39%
INM 1.46%
INMB -0.60%
INO 0.00%
INSM -0.05%
INTS 0.84%
INVA 1.55%
INZY 0.44%
IOBT -6.11%
IONS -0.37%
IOVA -0.25%
IPA 0.00%
IPHA -10.64%
IPSC 0.95%
IRON -0.09%
ISEE 0.38%
ITOS -0.84%
ITRM -2.61%
IVA 2.64%
IVVD 0.00%
JAGX -0.26%
JANX 0.17%
JAZZ 0.06%
JNCE 0.00%
JSPR -0.08%
JSPRW 2.33%
JUNS 0.00%
JUNSW 0%
KA -5.56%
KALV -0.42%
KDNY 0.22%
KMPH -0.34%
KNSA -0.05%
KNTE -0.38%
KOD 0.00%
KPRX 8.51%
KPTI -0.28%
KRBP 4.17%
KRON 0.00%
KROS -1.57%
KRRO -0.63%
KRTX 0.03%
KRYS 0.24%
KTRA 9.24%
KTTA -2.85%
KTTAW 8.62%
KURA 1.02%
KYMR -0.38%
KYTX -0.25%
KZIA 8.44%
KZR 0.65%
LABP 0.57%
LBPH -0.97%
LBPS 0.00%
LBPSW 14.81%
LEGN 0.19%
LENZ -1.30%
LEXX 2.46%
LEXXW -9.42%
LGND -0.46%
LGNDV 0.00%
LGVN -12.91%
LIAN 0.00%
LIFE 2.70%
LIPO -1.23%
LIXT 0.40%
LIXTW 27.74%
LJPC -0.32%
LMNL 0.12%
LOGC -0.72%
LPCN 2.99%
LPTX -1.93%
LQDA -0.23%
LRMR 1.13%
LSTA -4.97%
LTRN -2.24%
LUMO 0.00%
LVTX -1.42%
LXEO -1.05%
LXRX 0.87%
LYEL 3.12%
LYRA -1.26%
MACK 0.00%
MBIO 36.22%
MBRX -4.83%
MCRB -0.88%
MDGL 0.06%
MDNA -13.16%
MDWD 1.00%
MDXG 0.15%
MEIP 1.41%
MESO 2.12%
MGNX -2.80%
MGTA -7.74%
MGTX -1.14%
MGX 2.85%
MIRM 1.05%
MIRO 0.59%
MIST 2.96%
MITO 0.00%
MLEC -4.55%
MLECW 9.20%
MLND -5.36%
MLTX 0.09%
MLYS -0.66%
MNKD 0.00%
MNMD 0.53%
MNOV 0.00%
MNPR 3.39%
MOLN 2.88%
MOR -0.54%
MORF 1.36%
MREO 0.00%
MRKR -4.76%
MRNA -1.10%
MRNS 2.07%
MRSN 0.00%
MRTX -0.17%
MRUS -1.24%
MRVI 0.28%
MTCR -1.29%
MTEM 1.54%
MTP -18.50%
MURA -0.30%
MYMD -0.91%
NAMS -0.39%
NAMSW -7.61%
NAUT 1.17%
NBRV 0.71%
NBSE -1.56%
NBTX -6.05%
NCNA -1.64%
NERV 0.00%
NEXI -1.40%
NGM -1.28%
NGNE -3.95%
NKGN 0.78%
NKGNW 39.76%
NKTR -0.85%
NKTX -1.23%
NLSP 161.29%
NLSPW 8.38%
NMRA 0.53%
NMTR -42.97%
NOVN -24.84%
NRBO 0.45%
NRIX 3.47%
NRSN -4.95%
NRSNW 6.50%
NRXP 0.99%
NRXPW -15.65%
NRXS -6.06%
NTBL 2.92%
NTEC -12.45%
NTHI 0%
NTLA 0.00%
NTRBW -6.25%
NUVL 0.43%
NVAX -1.00%
NVCT 1.18%
NVIV -34.28%
NXTC 0.70%
NYMX -0.05%
OABI -0.47%
OABIW 13.46%
OBIO -0.87%
OBSV 0.00%
OCEA -3.21%
OCGN 3.37%
OCS -1.09%
OCUL -1.45%
OCUP 0.59%
ODT -4.27%
OKYO 0.00%
OLMA -0.47%
OMER 0.87%
OMGA 8.60%
ONCO 18.53%
ONCR -3.08%
ONCS 31.87%
ONCT -0.12%
ONCY -0.99%
ONTX -0.47%
ONVO -2.35%
OPNT 0.00%
OPT 0.80%
ORGS -1.72%
ORIC -0.13%
ORMP 0.00%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK 0.26%
OVID -5.04%
OYST 0.00%
PALI 0.86%
PASG -0.99%
PBLA 9.76%
PBM -0.02%
PBYI -0.63%
PCSA 5.71%
PCVX 0.31%
PDSB 0.19%
PEPG 0.70%
PGEN 0.63%
PHAR 2.17%
PHAS 0.00%
PHAT -0.60%
PHIO 6.80%
PHIOW 36.47%
PHVS -0.53%
PHXM -5.20%
PIRS -5.64%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -0.27%
PLUR 0.00%
PMN 0.00%
PMVP 0.00%
PNT 0.16%
PPBT 2.78%
PRAX 5.56%
PRDS 0.93%
PRLD 0.77%
PROG -3.47%
PROK 0.34%
PRQR -5.29%
PRTA 0.34%
PRTC -0.72%
PRTG 6.52%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV 0.00%
PSTX 1.81%
PTCT 0.06%
PTE -0.82%
PTGX 0.03%
PTIXW 2.50%
PULM 3.72%
PXMD -1.92%
PYPD -0.36%
PYXS 1.09%
QLGN 17.86%
QNCX -1.41%
QNRX 3.04%
QSI 0.75%
QSIAW 0.00%
QTTB 0.00%
QURE -0.75%
RAIN -1.63%
RANI 0.00%
RAPT -0.30%
RARE -0.28%
RCKT 0.19%
REGN 0.11%
RENB 0.00%
REPL -0.13%
RETA 0.02%
REUN -0.89%
REVB 5.26%
REVBU 3.46%
REVBW 25.20%
RGLS 0.42%
RGNX 1.12%
RIGL 2.54%
RLAY 0.21%
RLMD 0.00%
RLYB 0.00%
RNA -1.52%
RNAC -1.07%
RNAZ 0.00%
RNXT 0.75%
ROIV 0.28%
ROIVW 4.56%
RPHM -0.60%
RPRX 0.04%
RPTX 1.58%
RUBY 2.70%
RVLP -32.05%
RVMD -0.16%
RVMDW -23.93%
RVNC 0.36%
RVPH 0.00%
RVPHW 11.54%
RXDX 0.09%
RXRX -0.75%
RYTM 0.46%
RYZB 0.02%
RZLT 0.00%
SABS -2.75%
SABSW -32.14%
SAGE 0.71%
SANA -0.17%
SAVA -0.80%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI -10.91%
SCPH 0.00%
SCPS 0.00%
SEEL -1.16%
SEER -0.58%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO 1.55%
SGMT -0.47%
SGTX -2.56%
SIOX 22.63%
SLDB -0.40%
SLGL -2.22%
SLN -1.55%
SLNO 0.38%
SLRX 5.16%
SLS -3.19%
SMMT 0.57%
SNDX 0.13%
SNGX 0.79%
SNPX -3.97%
SONN -4.75%
SPPI -0.49%
SPRB 0.49%
SPRC -2.02%
SPRO 3.13%
SRNE 20.00%
SRPT 0.55%
SRRA 0.00%
SRRK -0.34%
SRZN -1.70%
STAB 0.00%
STOK -0.26%
STRO 0.63%
STSA 0.00%
STTK 0.40%
SURF -0.93%
SVRA -0.52%
SWTX -1.41%
SYBX -0.63%
SYRS -1.93%
TALS -0.73%
TARA -0.78%
TARS 1.72%
TBPH -0.12%
TCBP 1.78%
TCDA 0.00%
TCON 0.00%
TCRR 0.00%
TCRT -3.13%
TCRX -1.21%
TECH 0.07%
TENX -3.43%
TERN 0.00%
TFFP -2.05%
TGTX 0.31%
THRX 0.12%
TIL -2.06%
TLC 0.00%
TLSA 0.66%
TNGX 0.59%
TNXP 0.00%
TNYA 0.00%
TPST 0.34%
TRDA -3.61%
TRVI -0.18%
TRVN -1.88%
TSHA -6.45%
TSVT -0.49%
TTNP 1.45%
TVTX -0.27%
TYRA -0.39%
UBX 0.72%
UNCY -0.11%
URGN -7.50%
UTHR 0.08%
VACC 11.36%
VALN -2.51%
VAXX -0.11%
VBIV 1.15%
VBLT -8.77%
VCEL 0.50%
VCNX -1.54%
VCYT -0.09%
VERA -0.08%
VERU 0.50%
VERV -1.33%
VIGL -2.75%
VINC 1.05%
VIR -0.87%
VIRI -5.41%
VIRX -6.84%
VKTX -0.02%
VLON -13.04%
VNDA 0.63%
VOR 0.85%
VRCA 0.00%
VRDN -0.74%
VRNA 1.48%
VRPX -11.90%
VRTX -0.06%
VSTM 0.29%
VTGN 1.46%
VTVT -0.10%
VTYX -0.36%
VXRT 5.86%
VYGR 0.10%
VYNE 2.16%
VYNT 7.78%
WINT 5.59%
WVE -0.67%
XBIO 6.75%
XBIT -0.66%
XCUR -0.65%
XENE 0.30%
XERS 0.00%
XFOR -0.54%
XLO 2.96%
XLRN 0.00%
XNCR -0.41%
XOMA 0.00%
XOMAO -0.56%
XOMAP -0.14%
XRTX 2.97%
YMAB -0.38%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -2.20%
ZNTL -25.50%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2023-03-23 Klassen Preston Sell 842 211 Common Stock
2023-03-23 Klassen Preston Sell 842 211 Stock Option (right to buy)
2023-01-26 York Michael Sell 107 054 Common Stock
2023-01-26 Klassen Preston Sell 380 605 Common Stock
2022-12-21 Leonard Braden Michael Buy 120 099 Common Stock
INSIDER POWER
-22.47
Last 97 transactions
Buy: 12 877 287 | Sell: 12 262 808

Tūris Koreliacija

Ilgas: -0.64 (weak negative)
Trumpas: 0.81 (strong)
Signal:(57.111) Same movement expected

Metacrine, Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Metacrine, Inc. Koreliacija - Valiuta/Žaliavos

The country flag -0.38
( neutral )
The country flag -0.31
( neutral )
The country flag 0.00
( neutral )
The country flag 0.05
( neutral )
The country flag 0.00
( neutral )
The country flag 0.45
( neutral )

Metacrine, Inc. Finansinės ataskaitos

Annual 2021
Pajamos: $0.00
Bruto pelnas: $0.00 (0.00 %)
EPS: $-2.40
FY 2021
Pajamos: $0.00
Bruto pelnas: $0.00 (0.00 %)
EPS: $-2.40
FY 2020
Pajamos: $0.00
Bruto pelnas: $0.00 (0.00 %)
EPS: $-1.436
FY 2019
Pajamos: $0.00
Bruto pelnas: $0.00 (0.00 %)
EPS: $-1.520

Financial Reports:

No articles found.

Metacrine, Inc. Dividends

(Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0.580
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Metacrine, Inc. Dividend Information - Dividend Knight

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.580 2023-06-21
Last Dividend $0.580 2023-06-21
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 1 --
Total Paid Out $0.580 --
Avg. Dividend % Per Year 43.27% --
Score 4.01 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-06-18)
$1.160 Estimate 2.50 %
Dividend Stability
0.20 Very Poor
Dividend Score
4.01
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield
2023 $0.580 129.80%
2024 $0 0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Dividend History

Ex Date Amount Declaration Date Record Date Payment Date
21 Jun 2023 $0.580 30 Nov -0001 30 Nov -0001 30 Nov -0001

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
OXLC Dividend Diamond 2024-09-16 Monthly 14 15.03% 9.60
DMLP Dividend Diamond 2024-04-26 Quarterly 22 10.71% 9.35
OXSQ Dividend Diamond 2024-09-16 Monthly 21 12.73% 9.02
ARLP Dividend Royal 2024-05-07 Quarterly 26 9.67% 8.87
PNNT Dividend Royal 2024-06-14 Monthly 18 9.49% 8.82
MFIC Dividend Royal 2024-06-11 Quarterly 21 10.89% 8.79
SPOK Dividend Royal 2024-05-23 Quarterly 20 8.73% 8.72
PSEC Dividend Royal 2024-06-25 Monthly 21 9.03% 8.65
SBLK Dividend Royal 2024-06-06 Quarterly 17 13.10% 8.63
GBDC Dividend Royal 2024-11-29 Bi-Monthly 15 8.53% 8.62

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM01.50000[0 - 0.5]
returnOnAssetsTTM-0.7661.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM-0.8351.500-10.00-10.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM10.150.80010.008.00[1 - 3]
quickRatioTTM13.400.80010.008.00[0.8 - 2.5]
cashRatioTTM9.851.50010.0010.00[0.2 - 2]
debtRatioTTM0.177-1.5007.06-10.00[0 - 0.6]
interestCoverageTTM-50.811.000-10.00-10.00[3 - 30]
operatingCashFlowPerShareTTM-1.1202.00-0.373-0.747[0 - 30]
freeCashFlowPerShareTTM-1.1202.00-0.560-1.120[0 - 20]
debtEquityRatioTTM0.246-1.5009.01-10.00[0 - 2.5]
grossProfitMarginTTM01.000-3.33-3.33[0.2 - 0.8]
operatingProfitMarginTTM01.000-2.00-2.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-3.341.000-10.00-10.00[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score-0.578

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-0.4001.000-0.1410[1 - 100]
returnOnEquityTTM-0.8352.50-6.68-10.00[0.1 - 1.5]
freeCashFlowPerShareTTM-1.1202.00-0.373-1.120[0 - 30]
dividendYielPercentageTTM99.761.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM-1.1202.00-0.373-0.747[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.004001.500-3.360[0.5 - 2]
operatingCashFlowSalesRatioTTM01.000-2.500[0.1 - 0.5]
Total Score-0.917

Metacrine, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Metacrine, Inc.

Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.

Total Execution Time: 5.0389189720154 seconds
Number of API calls: 3
Number of DB calls: 9